October 2018

Two Israeli medical cannabis companies announced entering a strategic partnership to co-found development and clinical validation of a range of cannabis-based ADHD products. The two companies, Yom Chai and Kaneh-B, will conduct joint scientific trials in Israel utilizing various cannabinoids to bridge the gap between patients and doctors to bring scientifically-validated products to market. Scot […]

by

Two Israeli medical cannabis companies announced entering a strategic partnership to co-found development and clinical validation of a range of cannabis-based ADHD products. The two companies, Yom Chai and Kaneh-B, will conduct joint scientific trials in Israel utilizing various cannabinoids to bridge the gap between patients and doctors to bring scientifically-validated products to market. Scot […]

by

A new study has found no connection between legalized cannabis and problematic cannabis use, Marijuana Moment‘s Tom Angell reports. The study, published in the peer-reviewed journal Drugs in Context, looked at 329 frequent cannabis users in both states with legal cannabis and those without. The study was conducted by testing for impulsive behavior using a […]

by

Canopy Growth Corp. (CGC) announced that Spectrum Cannabis, the cannabis corporation’s wholly owned subsidiary, has partnered with the Ontario Long Term Care Association to pursue the development and implementation of a long-term care medical cannabis study aimed at seniors.  The stock is climbing more than 3% in morning trading following the announcement.  Canopy Growth and […]

by

A White House drug office official has offered assurances that a marijuana policy panel will be objective and dispassionate as it examines the impact of legalization in some states, a Colorado senator said. The vow came after BuzzFeed reported in August that the panel intended to portray marijuana as a national threat and criticize state efforts to […]

by

Recreational marijuana use is becoming more common, with its legalization in nine states and the District of Columbia, but in a study published on Wednesday, researchers suggest proceeding with caution as science considers its effects on the adolescent brain. Scientists at the University of Montreal who conducted research into how weed affects brain development over […]

by

I REFER to the letters “Trying out grandma’s remedy” (The Star, Sept 25) and “Law reform for medical marijuana” (Sept 28). The issue of cannabis oil, medical cannabis and the psychopathological effects of cannabis should be better understood by society, especially by the legal and legislative authorities. As a psychiatrist with experience in treating many […]

by

Visit the Canopy Growth Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors. Study will be one of the world’s first and largest medical cannabis pilot programs in the LTC space, registering as many as 500 residents SMITHS FALLS, ON and TORONTO, Oct. 3, 2018 /CNW/ – Canopy Growth […]

by

The effectiveness of cannabis to treat dementia will be studied at the University of Saskatchewan (U of S). The randomized and placebo-controlled study will take place at two extended care facilities in Saskatoon. Researchers will examine the degree patients can tolerate any side effects of the drug, dosage, and any adverse effects of dose escalation. […]

by

India Globalization Capital Inc. (IGC) is the latest high-flying cannabis stock to be targeted by Citron Research. The stock commentary website founded by activist short seller Andrew Left, which has also taken aim at CV Sciences Inc. (CVSI), Cronos Group Inc. (CRON), Namaste Technologies Inc. (N) and Tilray Inc. (TLRY) in the past, labeled IGC “the poster […]

by